CD274 and neoplasm: Tumor cells can hijack these immune checkpoints mainly by upregulation of CD274 (PD‐L1), which is strongly promoted by the EMT program (Zou et al, 2016; Terry et al, 2017; Jiang & Zhan, 2020; Kudo‐Saito et al, 2021).